CasLoc logo
All Cases PTAB Litigations UPC Oppositions

TEVA NEUROSCIENCE, INC. v. WATSON PHARMA, INC.

2:10-cv-05078

Overview

Case Number 2:10-cv-05078
Filing Date 2010-10-01
Status Terminated
Termination Date 2014-09-26
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:145 Patent Infringement
Jury Demand None

Parties

Mediator

LAYN R. PHILLIPS NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

LAYN R. PHILLIPS

IRELL & MANELLA, LLP

Tel: +1 (949) 760-5288

840 NEWPORT CENTER DRIVE, SUITE 400

Defendant

MYLAN LLC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

MYLAN INC. Operating Company

Represented By

5 Attorneys Listed

APOTEX CORP. Operating Company

Represented By

4 Attorneys Listed

DAMIAN P. CONFORTI

PODVEY, MEANOR, CATENACCI, HILDNER COCOZIELLO & CHATTMAN, PC

Tel: +1 (973) 623-1000

THE LEGAL CENTER, ONE RIVERFRONT PLAZA

NANCY ANN DEL PIZZO

Podvey Meanor Catenacci Hildner Cocoziello & Chattman, P.C.

Tel: +1 (973) 623-6183
Fax: +1 (973) 947-7539

One Riverfront Plaza, Suite 800

GREGORY D. MILLER

PODVEY, MEANOR, CATENACCI, HILDNER, COCOZIELLO & CHATTMAN PC

Tel: +1 (973) 623-1000

THE LEGAL CENTER, ONE RIVERFRONT PLAZA

SARAH CHRISTINE MITCHELL

PODVEY MEANOR

Tel: +1 (973) 623-1000

PODVEY MEANOR, ONE RIVERFRONT PLAZA

WATSON LABORATORIES, INC. Operating Company

Represented By

2 Attorneys Listed

TEVA PHARMACEUTICALS USA, INC. Operating Company

Represented By

2 Attorneys Listed

MYLAN PHARMACEUTICALS, INC. Operating Company

Represented By

5 Attorneys Listed

Plaintiff

TEVA NEUROSCIENCE, INC. Operating Company

Represented By

2 Attorneys Listed

Counter Claimant

ORGENUS PHARMA, INC. Operating Company

Represented By

2 Attorneys Listed

APOTEX INC. Operating Company

Represented By

4 Attorneys Listed

DAMIAN P. CONFORTI

PODVEY, MEANOR, CATENACCI, HILDNER COCOZIELLO & CHATTMAN, PC

Tel: +1 (973) 623-1000

THE LEGAL CENTER, ONE RIVERFRONT PLAZA

NANCY ANN DEL PIZZO

Podvey Meanor Catenacci Hildner Cocoziello & Chattman, P.C.

Tel: +1 (973) 623-6183
Fax: +1 (973) 947-7539

One Riverfront Plaza, Suite 800

GREGORY D. MILLER

PODVEY, MEANOR, CATENACCI, HILDNER, COCOZIELLO & CHATTMAN PC

Tel: +1 (973) 623-1000

THE LEGAL CENTER, ONE RIVERFRONT PLAZA

SARAH CHRISTINE MITCHELL

PODVEY MEANOR

Tel: +1 (973) 623-1000

PODVEY MEANOR, ONE RIVERFRONT PLAZA

Counter Defendant

WATSON PHARMA PRIVATE LTD. -UNIT IV Operating Company

Represented By

1 Attorneys Listed

WATSON PHARMACEUTICAL INC. Operating Company

Represented By

1 Attorneys Listed

WATSON PHARMA, INC. Operating Company

Represented By

1 Attorneys Listed

ORCHID HEALTHCARE NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

ORCHID CHEMICALS & PHARMACEUTICALS LTD. Operating Company

Represented By

2 Attorneys Listed

TEVA PHARMACEUTICALS INDUSTRIES, LTD. Operating Company

Represented By

2 Attorneys Listed

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7572834
Rasagiline formulations and processes for their preparation
Filed: 2006-12-05
Issued: 2009-08-11
Expiring Soon (15 days)
Expires: 2026-12-05

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Narrowing Window — Less than 6 months of enforceable term remains. Courts rarely grant preliminary or permanent injunctions when term expiration is imminent.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

100

Dispositive

59

Granted

9

Denied

3

Pending / Review

58

Motions by Category

Procedural / Extension Motion 23 Motion to Dismiss 59 Claim Construction / Markman Filing 16 Motion to Strike / Sanctions 2

Key Dispositive Motions & Rulings

Motion to Dismiss Denied
ORDER denying pltf's motion to dismiss the inequitable conduct counterclaims and/or affirmative defenses of Orchid Watson, Maylan and Apotex (Docket Entry Nos. ...
Entry #464 • 2013-04-12 Document →
Motion to Dismiss Pending / Under Review
ORDER administratively terminating 282 Motion to Strike ; administratively terminating 282 Motion to Dismiss ; administratively terminating 283 Motion to Dismis...
Entry #386 • 2012-07-19 Document →
Motion to Dismiss Pending / Under Review
Letter from Jason B. Lattimore re 287 Response in Support of Motion. (Attachments: # 1 Orchids [Proposed] Sur-Reply to Tevas Consolidated Reply Brief in Support...
Entry #291 • 2011-12-09 Document →
Motion to Dismiss Pending / Under Review
RESPONSE in Support re 282 MOTION to Strike MOTION to Dismiss filed by TEVA NEUROSCIENCE, INC., TEVA PHARMACEUTICALS INDUSTRIES, LTD., TEVA PHARMACEUTICALS USA,...
Entry #287 • 2011-12-06 Document →
Motion to Dismiss Pending / Under Review
RESPONSE in Support re 283 MOTION to Dismiss MOTION to Strike filed by TEVA NEUROSCIENCE, INC., TEVA PHARMACEUTICALS INDUSTRIES, LTD., TEVA PHARMACEUTICALS USA,...
Entry #288 • 2011-12-06 Document →
Motion to Dismiss Pending / Under Review
MEMORANDUM in Opposition re 282 MOTION to Strike MOTION to Dismiss filed by ORCHID CHEMICALS & PHARMACEUTICALS LTD.. (Attachments: # 1 Certificate of Service)(L...
Entry #284 • 2011-12-02 Document →

Docket Entries

(600 total)
Pleading / Complaint

COMPLAINT against MYLAN INC., MYLAN LLC., MYLAN PHARMACEUTICALS, INC., ORCHID CHEMICALS & PHARMACEUTICALS LTD., ORCHID HEALTHCARE, ORGENUS PHARMA, INC., WATSON LABORATORIES, INC., WATSON PHARMA PRIVATE LTD. -UNIT IV, WATSON PHARMA, INC., WATSON PHARMACEUTICAL INC. ( Filing fee $ 350 receipt number 3349944.) NO JURY DEMANDED., filed by TEVA PHARMACEUTICALS USA, INC., TEVA NEUROSCIENCE, INC., TEVA PHARMACEUTICALS INDUSTRIES, LTD.. (Attachments: # 1 Civil Cover Sheet, # 2 Certificate of Non-Arbitrability)(rac, ) (Entered: 10/06/2010)

Entry #1 • 2010-10-01
1

Corporate Disclosure Statement by TEVA PHARMACEUTICALS USA, INC. identifying Teva Pharmaceuticals Industries, Ltd. as Corporate Parent.. (rac, ) (Entered: 10/06/2010)

Entry #2 • 2010-10-01
1

Corporate Disclosure Statement by TEVA PHARMACEUTICALS INDUSTRIES, LTD. identifying None as Corporate Parent.. (rac, ) (Entered: 10/06/2010)

Entry #3 • 2010-10-01
1

Corporate Disclosure Statement by TEVA NEUROSCIENCE, INC. identifying Teva Pharmaceutical Industries Ltd. as Corporate Parent.. (rac, ) (Entered: 10/06/2010)

Entry #6 • 2010-10-01
1

AO120 Patent/Trademark Form filed. (rac, ) (Entered: 10/06/2010)

Entry #4 • 2010-10-06
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc